NO20005951L - Fremgangsmåte for rensning av Borrelia lipoprotein OspA - Google Patents

Fremgangsmåte for rensning av Borrelia lipoprotein OspA

Info

Publication number
NO20005951L
NO20005951L NO20005951A NO20005951A NO20005951L NO 20005951 L NO20005951 L NO 20005951L NO 20005951 A NO20005951 A NO 20005951A NO 20005951 A NO20005951 A NO 20005951A NO 20005951 L NO20005951 L NO 20005951L
Authority
NO
Norway
Prior art keywords
purification
procedure
lipoprotein ospa
borrelia
borrelia lipoprotein
Prior art date
Application number
NO20005951A
Other languages
English (en)
Other versions
NO20005951D0 (no
Inventor
Pierre Desmons
Robert Liveyns
Emmanuel Mertens
Benoit Champluvier
Dominique Plainchamp
Yvon Corazza
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of NO20005951D0 publication Critical patent/NO20005951D0/no
Publication of NO20005951L publication Critical patent/NO20005951L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en fremgangsmåte for rensning av Borrelia-lipoprotein-OspA egnet for human klinisk anvendelse hvori en vertcelle som uttrykker lipoprotein-OspA lyseres ved tilstedeværelse av zwitterjonisk detergent etterfulgt av flere kromatografiske trinn i et ikke-jonisk detergent.
NO20005951A 1998-05-26 2000-11-24 Fremgangsmåte for rensning av Borrelia lipoprotein OspA NO20005951L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9811219.6A GB9811219D0 (en) 1998-05-26 1998-05-26 Novel process
PCT/EP1999/003602 WO1999061473A1 (en) 1998-05-26 1999-05-25 Method for purification of borrelia lipoprotein ospa

Publications (2)

Publication Number Publication Date
NO20005951D0 NO20005951D0 (no) 2000-11-24
NO20005951L true NO20005951L (no) 2001-01-24

Family

ID=10832669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005951A NO20005951L (no) 1998-05-26 2000-11-24 Fremgangsmåte for rensning av Borrelia lipoprotein OspA

Country Status (17)

Country Link
EP (1) EP1080109B1 (no)
JP (1) JP2002516340A (no)
KR (1) KR20010043817A (no)
CN (1) CN1311795A (no)
AT (1) ATE244730T1 (no)
AU (1) AU752196B2 (no)
BR (1) BR9910715A (no)
CA (1) CA2333167A1 (no)
DE (1) DE69909469T2 (no)
GB (1) GB9811219D0 (no)
HU (1) HUP0102774A3 (no)
IL (1) IL139749A0 (no)
NO (1) NO20005951L (no)
PL (1) PL345273A1 (no)
TR (1) TR200003468T2 (no)
WO (1) WO1999061473A1 (no)
ZA (1) ZA200006873B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009004866A (es) 2006-11-03 2009-05-19 Schering Plough Ltd Vacuna para enfermedad de lyme canina.
AU2008217189B2 (en) * 2007-02-22 2013-06-13 Baxalta GmbH Method of purification of hydrophobic proteins
JP6227407B2 (ja) 2010-05-14 2017-11-08 バクスアルタ インコーポレイテッド Ｏｓｐａキメラおよびそのワクチンでの使用法
CA2879689A1 (en) 2012-07-27 2014-01-30 Baxter International Inc. Compositions comprising chimeric ospa molecules and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
PT100980B (pt) * 1991-10-18 1999-07-30 Connaught Lab Proteinas recombinantes de borrelia, seu processo de producao, vacina contra infeccao por borrelia e agente de imunodiagnostico para a sua deteccao

Also Published As

Publication number Publication date
CN1311795A (zh) 2001-09-05
JP2002516340A (ja) 2002-06-04
CA2333167A1 (en) 1999-12-02
AU752196B2 (en) 2002-09-12
ATE244730T1 (de) 2003-07-15
KR20010043817A (ko) 2001-05-25
TR200003468T2 (tr) 2002-05-21
PL345273A1 (en) 2001-12-03
EP1080109A1 (en) 2001-03-07
HUP0102774A2 (hu) 2001-11-28
NO20005951D0 (no) 2000-11-24
EP1080109B1 (en) 2003-07-09
BR9910715A (pt) 2001-01-30
DE69909469D1 (de) 2003-08-14
GB9811219D0 (en) 1998-07-22
AU4367999A (en) 1999-12-13
DE69909469T2 (de) 2004-04-15
WO1999061473A1 (en) 1999-12-02
HUP0102774A3 (en) 2003-04-28
ZA200006873B (en) 2001-07-05
IL139749A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
NO984524D0 (no) Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer
ID18182A (id) Proses untuk merubah gas menjadi cairan
PT841946E (pt) Metodos para tratamento de asma alergica
NO982185D0 (no) Nye makrosykliske forbindelser som metalloproteaseinhibitorer
NO973539D0 (no) Prolinderivater anvendelige som inhibitorer for human leukocyttelastase
NO20015247D0 (no) Glysinspaltingssysteminhibitorer som potensielle antipsykotika
NO992309D0 (no) FremgangsmÕte for anvendelse av cyklooksygenase-2 inhibitorer som anti-angiogene midler
NO971347L (no) DNA som koder for humant papillomvirus type 6A
NO20005951L (no) Fremgangsmåte for rensning av Borrelia lipoprotein OspA
NO963108D0 (no) Substituerte kanelsyreguanidider, fremgangsmåte for fremstilling, anvendelse som medikament eller diagnostikum som inneholder disse
DK1170591T3 (da) Fremgangsmåde til identifikation af kombinationer af forbindelser som terapeutiske midler
ID22906A (id) Proses untuk memurnikan siloksana
AU2002339305A1 (en) Method for purifying full blood
NO991175D0 (no) Anvendelse av proteiner som midler mot autoimmune sykdommer
AU2000260501A1 (en) Process for removing toxins from bodily fluids using zirconium or titanium microporous compositions
DE69814835D1 (de) Entferner für keratöse komedonen
NO20000995D0 (no) Optisk rene camptotecin analoger, optisk rent mellomprodukt, fremgangsmõte for fremstilling av disse
ID24469A (id) Proses pembuangan senyawa organopospor yang terkandung dalam gas atau cairan
AU2002366004A1 (en) Process for the purification of contaminated oils
AU2001284741A1 (en) Method for purification of acarbose
AU2002333508A1 (en) Method to identify modulators for human 3alpha-hydroxysteroid dehydrogenase
IT1283044B1 (it) Metodo per la sbianca di detergenti
AU2001287669A1 (en) Specific autoimmune reactions against isomerised/optically inverted epitopes: application for treatment of autoimmune diseases
ID19354A (id) Proses untuk pemurnian butil akrilat
AU2002216305A1 (en) Use of sequestrants for treating prion diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application